# EDGAR Filing Document

**Accession Number:** 0001803977
**File Stem:** 0001493152-26-005710
**Filing Date:** 2026-2
**Character Count:** 19870
**Document Hash:** 2b165385954976ffc14dc02ee9882483
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-005710.hdr.sgml**: 20260209

**ACCESSION NUMBER**: 0001493152-26-005710

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 14

**CONFORMED PERIOD OF REPORT**: 20260126

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260209

**DATE AS OF CHANGE**: 20260209

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Limitless X Holdings Inc.
- **CENTRAL INDEX KEY:** 0001803977
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 811034163
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-56453
- **FILM NUMBER:** 26609757

**BUSINESS ADDRESS:**
- **STREET 1:** 9777 WILSHIRE BLVD.,
- **STREET 2:** SUITE 400,
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212
- **BUSINESS PHONE:** 720-273-0433

**MAIL ADDRESS:**
- **STREET 1:** 9777 WILSHIRE BLVD.,
- **STREET 2:** SUITE 400,
- **CITY:** BEVERLY HILLS
- **STATE:** CA
- **ZIP:** 90212

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIO LAB NATURALS, INC.
- **DATE OF NAME CHANGE:** 20200219

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

January 26, 2026

Date of Report (Date of earliest event reported)

**<u>LIMITLESS X HOLDINGS INC.</u>**

(Exact name of registrant as specified in its charter)

---

| | | |
|:---|:---|:---|
| **Delaware** | **000-56453** | **81-1034163** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (IRS Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| **9777 Wilshire Blvd., #400**<br>**Beverly Hills, CA** | **90212** |
| (Address of principal executive offices) | (Zip Code) |

---

**(855) 413-7030**

------

Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| N/A | N./A | N/A |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Agreement.**

***Binding Letter of Intent***

 ****

On January 26, 2026, Bodycor, Inc., a Nevada corporation ("Bodycor"), and Limitless X Holdings Inc., a Delaware corporation (the "Company", which is the issuer of the Common Stock described herein), entered into a Binding Letter of Intent (the "LOI") with Ding Easy AI, LLC, a Delaware limited liability company ("Ding"), and the equityholders of Ding ("Ding Owners"). Ding is a web and mobile platform that leverages its partnership with Maplebear Inc. d/b/a Instacart (NASDAQ: CART) to assist users in achieving health goals through the use of artificial intelligence to plan meals and generate grocery lists based on individualized dietary needs and budget requirements. Ding is wholly owned and controlled by Daniel Sanders, who also serves as the President of Limitless X, Inc., the Company's wholly-owned subsidiary which sells nutritional supplements. As a result, the LOI constitutes a related-party transaction under Item 404(a) of Regulation S-K. The transaction terms and the President's interest were reviewed and approved by the Audit Committee.

Pursuant to the LOI, Bodycor will acquire from the Ding Owners sixty percent (60%) of the equity interests of Ding on a fully diluted basis, assumed for valuation purposes to include an employee equity pool of fifteen percent (15%) and a pre-money valuation of fifteen million dollars ($15,000,000) (the "Valuation"). In exchange, the Ding Owners will receive shares of common stock of the Company ("Common Stock") having an aggregate value of nine million dollars ($9,000,000) based on the volume-weighted average price per share of the Common Stock. The Comon Stock will be issued as restricted securities pursuant to Rule 144 of the Securities Act of 1933, as amended (the "Act"). Additionally, Bodycor will provide Ding with one million seven hundred and fifty thousand dollars ($1,750,000) of growth capital ("Growth Capital"), subject to Bodycor's satisfactory completion of due diligence and the issuance of a fairness opinion with respect to the Valuation.

The first seven hundred and fifty thousand dollars ($750,000) of Growth Capital will be funded in three (3) tranches of two hundred and fifty thousand dollars ($250,000), each tied to an agreed use-of-proceeds schedule, budget categories, spend thresholds, and reporting covenants. Bodycor's disbursement of the remaining one million dollars ($1,000,000) of Growth Capital will be contingent upon the achievement of certain objective and auditable milestones including revenue targets and user metrics. The timing and funding of the Growth Capital per the LOI is not binding on the parties.

Following Ding achieving a valuation of forty million dollars ($40,000,000), as determined pursuant to the LOI, Bodycor will have the right, but not the obligation, to acquire from the Ding Owners the remaining forty percent (40%) of the equity interests of Ding in a subsequent transaction (the "Second Sale") in exchange for Common Stock having an aggregate value of sixteen million dollars ($16,000,000) based on the volume-weighted average price per share of the Common Stock immediately preceding the Second Sale. The LOI provides for an exclusivity period of one hundred and twenty (120) days.

The Company will provide audited financial statements of Ding within 60 days after the acquisition is completed.

The foregoing description of the LOI does not purport to be complete and is qualified in its entirety by reference to the full text of such document, a copy of which is filed as an exhibit to this Current Report on Form 8-K.

**Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**

To the extent applicable, the information contained in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

**Item 9.01 Financial Statements and Exhibits.**

---

| | |
|:---|:---|
| (d) | Exhibits |
| 10.1 | [Binding Letter of Intent by and among Bodycor Inc., Limitless X Holdings Inc., and Ding Easy AI, LLC, dated January 26, 2026](ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
| | | **LIMITLESS X HOLDINGS INC.** | **LIMITLESS X HOLDINGS INC.** |
| Date: | February 9, 2026 | By: | */s/ Jaspreet Mathur* |
|  |  | Name: | Jaspreet Mathur |
|  |  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**Binding Letter of Intent**

This Binding Letter of Intent ("LOI" or "Agreement") is entered into as of January 26, 2026 (the "Effective Date"), by and among Bodycor, Inc., a Nevada corporation ("Bodycor"), Limitless X Holdings, Inc., a Nevada corporation ("LIMX"), solely with respect to the issuance of any LIMX securities contemplated herein, Ding Easy AI LLC, a Delaware corporation ("Ding"), and the equity holders of Ding listed on Exhibit A (collectively, the "Ding Shareholders"). Bodycor, Ding, and the Ding Shareholders are sometimes referred to individually as a "Party" and collectively as the "Parties."

1. Transaction Overview

Subject to the terms and conditions set forth herein, Bodycor intends to acquire a controlling equity interest in Ding pursuant to a stock-for-stock transaction, together with a conditional growth capital facility and an upside call option, all as further described below.

2. Initial Acquisition

Bodycor shall acquire, at the closing of the Initial Acquisition (the "Closing"), 60% of the fully diluted equity of Ding, as determined pursuant to a capitalization schedule setting forth all prospective security issuances and giving effect to an employee equity pool equal to up to 15% of the issued and outstanding shares on the Closing date. The capitalization schedule and any other documents required to effectuate this Agreement will be prepared within a reasonable time following execution hereof. This Agreement will remain binding against the Parties and shall remain in full force and effect through any delay in the preparation of further documents, per the section on definitive agreements hereinbelow.

2.1 Valuation

For purposes of the Initial Acquisition consideration mechanics only, Ding shall be valued at a pre-money enterprise value of $15,000,000, subject to adjustments, if any, following completion of satisfactory due diligence by BodyCor.

2.2 Equity Acquired

At the Closing, Bodycor shall acquire 60% of the fully diluted equity of Ding.

2.3 Consideration

As consideration, and subject to applicable securities laws, the Ding Shareholders shall receive shares of restricted common stock of LIMX (the "Consideration Shares"), with an aggregate value target of $9,000,000, with the number of shares determined based on the volume-weighted average price of the shares of common stock of LIMX, the parent company of BodyCor, during the ninety (90) day period preceding the closing date. The Consideration Shares will be allocated pro rata among the Ding Shareholders based on their respective ownership interests. The Consideration Shares can be resold pursuant to Rule 144 of the Securities Act of 1933, as amended.

3. Growth Capital Commitment

Subject to the terms of this Agreement and the definitive agreements, Bodycor may provide Ding with up to $1,750,000 in cash (the "Growth Capital") to fund platform growth in accordance with a mutually agreed growth plan, budget, and use-of-proceeds schedule, together with reporting, control, and audit rights customary for growth capital facilities. Disbursement of Growth Capital shall be at Bodycor's sole discretion and subject to satisfaction of conditions precedent, including those below.

3.1 Conditions Precedent

No disbursement shall be required for growth capital unless and until (a) Bodycor has completed due diligence satisfactory to Bodycor in its sole discretion, and (b) a fairness opinion issued by an investment bank acceptable to Bodycor confirms a valuation of Ding at or above $15,000,000, ($9,000,000 for 60% initial acquisition).

3.2 Condition Precedent- Instacart

Ding represents and warrants that Bodycor shall have full access to the Instacart partnership and that all revenue splits and other obligations per this Agreement will be tied to the API portal integrated into the Instacart app Account Number 6563786 and not through any other entity (including Ding). The Instacart account shall be fully controlled by Bodycor in favor of the partnership between the Parties.

3.3 Initial Funding Tranches

Subject to the above conditions, the first $750,000 will be funded in up to three tranches of approximately $250,000 each, tied to an agreed use-of-proceeds schedule, budget categories, spend thresholds, and reporting covenants.

3.4 Milestone-Based Funding

Subject to satisfaction of conditions precedent and performance under the initial tranches, Bodycor may fund up to an additional $1,000,000, contingent upon achievement and maintenance of objective, auditable milestones including revenue targets and active user metrics, all to be validated by agreed third-party or system-of-record reporting.

3.5 Funding Timelines

Any timeline for funding, including an illustrative expectation of $750,000 within approximately four months post-Closing and up to $1,750,000 within approximately twelve months post-Closing, shall be non-binding and subject to market conditions, operational performance, and satisfaction of conditions precedent.

4. Governance, Information, and Controls

From and after Closing, Bodycor shall have customary governance and oversight rights commensurate with a 60% controlling equity position, including board representation, consent rights over material actions, information rights, inspection and audit rights, budget approval, and protective provisions, in each case to be set forth in the definitive agreements.

5. Upside Call Option ("Call Option")

Upon Ding achieving a valuation of $40,000,000, as determined in good faith by BodyCor and validated by an independent valuation firm or investment bank acceptable to Bodycor, Bodycor shall have the right, but not the obligation, to acquire the remaining 40% equity interest in Ding pursuant to the terms below.

5.1 Call Mechanics and Consideration

BodyCor shall exercise the Call Option by sending written notice to Ding at least ten (10) days prior to the closing date of the Call Option (the "Second Closing"). Upon exercise of the Call Upon exercise of the Call Option, the remaining Ding equity holders shall receive consideration from BodyCor in the form of shares of common stock of LIMX in the amount of $16 million (40% of $40 million). The LIMX share count shall be calculated based on the volume-weighted average price of LIMX common stock during the ninety (90) day period preceding the Second Closing.

6. Binding Provisions

This Agreement is binding upon BodyCor and Ding, and their successors and assigns. The provisions relating to issuance of stock by LIMX in Section 2.3 and 5.1. are binding upon LIMX and its successors and assigns.

7. Exclusivity

For a period of one hundred twenty (120) days from the Effective Date (the "Exclusivity Period"), Ding and the Ding Shareholders shall not, and shall cause their respective affiliates and representatives not to, directly or indirectly, solicit, initiate, encourage, participate in, or enter into any discussions or negotiations regarding, or furnish any information in connection with, any proposal or offer concerning any equity or debt investment in, or any sale, transfer, joint venture, licensing, or other t prior written consent. Ding shall promptly notify Bodycor of any unsolicited approaches and provide reasonable detail thereof.

During the Exclusivity Period until the Initial Closing, LIMX, Bodycor, and their respective officers, directors, and employees agree that they will not intentionally: (a) contact any vendors, suppliers, or other key contacts identified by Ding in writing to discuss Ding or its business relationships, unless Ding has pre-approved such contact; (b) disclose, reveal, or otherwise make available any confidential information relating to Ding to any third party; or (c) take any action that harms Ding or its business interests. Notwithstanding the foregoing, Daniel Sanders, as an officer of LIMX and Ding, shall be exempt from this requirement.

8. Confidentiality

All terms of this LOI, the fact of discussions, and all information exchanged shall be kept confidential and used solely for evaluating the transactions contemplated hereby, except as required by law or as mutually agreed in writing. To the extent a separate nondisclosure agreement is in effect, such agreement shall remain in full force and govern, and this LOI shall supplement, not diminish, such protections.

9. Governing Law; Venue; Waiver of Jury Trial

This Agreement shall be governed by and construed in accordance with the laws of the State of Nevada, without regard to conflicts of law principles. The Parties consent to the exclusive jurisdiction of state and federal courts located in Clark County, Nevada, and waive any objection based on forum non conveniens. EACH PARTY WAIVES ANY RIGHT TO A TRIAL BY JURY IN ANY PROCEEDING ARISING OUT OF OR RELATING TO THIS LOI OR THE TRANSACTIONS CONTEMPLATED HEREBY.

10. Expenses

Each Party shall bear its own fees and expenses incurred in connection with this Agreement and the contemplated transactions, whether or not any definitive agreement is executed, except as may be expressly provided in any binding expense reimbursement agreement executed by the Parties.

11. Remedies; Specific Performance; Injunctive Relief

The Parties acknowledge that a breach of any provisions in this Agreement would cause irreparable harm for which monetary damages would be an inadequate remedy, and agree that the non-breaching Party shall be entitled to equitable relief, including specific performance and injunctive relief, in addition to any other remedies available at law or in equity.

12. Definitive Agreements; Control

The Parties agree to negotiate in good faith to enter into definitive agreements consistent with this Agreement; provided, that in the event of any conflict between this Agreement and any term sheet or discussion, this Agreement shall control unless expressly superseded in writing in a definitive agreement. The definitive agreements will include customary representations and warranties, pre- and post-Closing covenants, interim operating covenants, conditions precedent (including satisfactory due diligence and third-party consents), indemnities, survival, caps, baskets, and other terms customary for transactions of this nature. This Agreement and the terms and conditions hereon shall remain bin ding against the Parties pending the preparation and execution of definitive agreements.

13. Counterparts; Electronic Signatures

This LOI may be executed in counterparts, each of which shall be deemed an original, and all of which together shall constitute one and the same instrument. Signatures delivered by electronic transmission shall be deemed original signatures for all purposes.

[*Separate signature page to follow*]

IN WITNESS WHEREOF, the Parties have executed this Binding Letter of Intent as of the Effective Date first written above.

---

| | |
|:---|:---|
| **BODYCOR INC.** | **BODYCOR INC.** |
| By: | */s Jaspreet Mathur* |
|  | Jaspreet Mathur, CEO |
| **LIMILTESS X HOLDINGS, INC.** (solely with respect to Sections 2.3 and 5.1) | **LIMILTESS X HOLDINGS, INC.** (solely with respect to Sections 2.3 and 5.1) |
| By: | */s/ Danielle Young* |
|  | Danielle Young, COO |
| **DING:** | **DING:** |
| By: | */s/ Daniel Sanders* |
| Daniel Sanders, Authorized Representative | Daniel Sanders, Authorized Representative |
| The Equity Holders of **DING EASY AI LLC** listed on Exhibit A | The Equity Holders of **DING EASY AI LLC** listed on Exhibit A |

---

**EXHIBIT A**

SHAREHOLDERS OF DING

Daniel Sanders